Immunosuppressive agents for the treatment of interstitial pneumonia associated with amyopathic dermatomyositis, dermatomyositis and polymyositis: Prognostic factors of the clinical outcome.

被引：0
|
作者：
Azuma, K [1 ]
Yamasaki, Y [1 ]
Ogawa, H [1 ]
Yamasaki, M [1 ]
Okubo, M [1 ]
Yamada, H [1 ]
Ozaki, S [1 ]
机构：
[1] St Marianna Med Univ, Sch Med, Kawasaki, Kanagawa 213, Japan
来源：
ARTHRITIS AND RHEUMATISM | 2003年 / 48卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
728
引用
收藏
页码：S310 / S310
页数：1
相关论文
共 50 条
  • [31] A clinical analysis of prognostic factors for dermatomyositis-associated interstitial lung disease
    Zhang, Ti
    Zhang, Ju
    Liu, Xin
    Zhang, Lanling
    Zhao, Dongbao
    Wu, Xin
    Xu, Huji
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (06): : 5903 - 5911
  • [32] Therapeutic plasma exchange for clinically amyopathic dermatomyositis (CADM) associated with rapidly progressive interstitial pneumonia
    Yamagata, Akira
    Arita, Machiko
    Tanaka, Ayaka
    Tokioka, Fumiaki
    Yoshida, Tomohiro
    Nishimura, Keisuke
    Ishida, Tadashi
    JOURNAL OF CLINICAL APHERESIS, 2020, 35 (05) : 435 - 443
  • [33] Transbronchial biopsy is clinically useful in classifying patients with interstitial pneumonia associated with polymyositis and dermatomyositis
    Mochimaru, Hiroshi
    Kawamoto, Masashi
    Enomoto, Tatsuji
    Saitoh, Yoshinobu
    Abe, Shinji
    Nei, Takahito
    Fukuda, Yuh
    Kudoh, Shoji
    RESPIROLOGY, 2008, 13 (06) : 863 - 870
  • [34] Clinical Characteristics Dermatomyositis/Polymyositis Associated Interstitial Lung Disease According to the Autoantibody
    Kishaba, T.
    Nei, Y.
    Ibuki, S.
    Momose, M.
    Nagano, H.
    Yamashiro, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [35] Prognostic analysis of MDA5-associated clinically amyopathic dermatomyositis with interstitial lung disease
    Wang, Wen
    Sun, Xiang
    Xu, Yan
    Tan, Wenfeng
    Liu, Ye
    Zhou, Jun
    IMMUNITY INFLAMMATION AND DISEASE, 2024, 12 (06)
  • [36] The efficacy of calcineurin inhibitors for the treatment of interstitial lung disease associated with polymyositis/dermatomyositis
    Kurita, T.
    Yasuda, S.
    Amengual, O.
    Atsumi, T.
    LUPUS, 2015, 24 (01) : 3 - 9
  • [37] Clinical analysis and outcome of interstitial lung disease complicated with juvenile dermatomyositis and juvenile polymyositis
    Sato, Satoshi
    Uejima, Yoji
    Nanbu, Meika
    Suganuma, Eisuke
    Takano, Tadamasa
    Tanaka, Risa
    Kabuki, Tomoyuki
    Oguma, Eiji
    Oh-Ishi, Tsutomu
    Kawano, Yutaka
    MODERN RHEUMATOLOGY, 2017, 27 (04) : 652 - 656
  • [38] Sequential changes of KL-6 in sera of patients with interstitial pneumonia associated with polymyositis/dermatomyositis
    Bandoh, S
    Fujita, J
    Ohtsuki, Y
    Ueda, Y
    Hojo, S
    Tokuda, M
    Dobashi, H
    Kurata, N
    Yoshinouchi, T
    Kohno, N
    Takahara, J
    ANNALS OF THE RHEUMATIC DISEASES, 2000, 59 (04) : 257 - 262
  • [39] Tacrolimus in Patients With Interstitial Pneumonia Associated With Polymyositis or Dermatomyositis: Interim Report of Postmarketing Surveillance in Japan
    Kuwana, Masataka
    Wakasugi, Naoko
    Furuya, Toshinori
    Uno, Satoshi
    Suda, Takafumi
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (07) : 707 - 718
  • [40] Predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis or dermatomyositis: a retrospective study
    Ji Su-yun
    Zeng Fan-qin
    Guo Qing
    Tan Guo-zhen
    Tang Hong-feng
    Luo Yi-jin
    Tang Zeng-qi
    Han Yan-fang
    CHINESE MEDICAL JOURNAL, 2010, 123 (05) : 517 - 522
12345